Last updated on August 2018

Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer


Brief description of study

To compare the efficacy of AM0010 in combination with FOLFOX versus FOLFOX alone in patients with metastatic pancreatic cancer as measured by overall survival

Detailed Study Description

This is an open-label, multi-center, randomized, Phase 3 study designed to compare the efficacy and safety of AM0010 in combination with FOLFOX versus FOLFOX alone in patients with metastatic adenocarcinoma of the pancreas who have progressed on one prior gemcitabine containing regimen.

Clinical Study Identifier: NCT02923921

Contact Investigators or Research Sites near you

Start Over

Tomislav Dragovich, MD

Banner MD Anderson Cancer Center
Gilbert, AZ United States
0.47miles
  Connect »